3rd Quarter - Amendment

THORN RUN PARTNERS for NOVARTIS CORPORATION

Firm
Client
Income
$50,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report Oct 15, 2019 $50,000 Replaced
3rd Quarter - Amendment (this page) Oct 30, 2019 $50,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to Medicare and Medicaid reimbursement of biosimilars and drugs.

LobbyistCovered position, as disclosed
JESSIE HOWE BRAIRTON —
ALEX DELPIZZO —
GARY PALMQUIST —
ANDREW ROSENBERG —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Implementation issues related to the Patient Protection and Affordable Care Act (P.L.111-148). Issues related to pharmaceutical pricing and biosimilars.

LobbyistCovered position, as disclosed
JESSIE HOWE BRAIRTON —
ALEX DELPIZZO —
GARY PALMQUIST —
ANDREW ROSENBERG —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.